| Autor: |
Volel BA; University Clinical Hospital #3 of Sechenov First Moscow State Medical University Ministry of Health, Moscow, Russia., Petelin DS; University Clinical Hospital #3 of Sechenov First Moscow State Medical University Ministry of Health, Moscow, Russia., Poluektov MG; Sechenov First Moscow State Medical University Ministry of Health, Moscow, Russia. |
| Jazyk: |
ruština |
| Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2019; Vol. 119 (4. Vyp. 2), pp. 63-68. |
| DOI: |
10.17116/jnevro201911904263 |
| Abstrakt: |
Insomnia is one of the most common symptoms of mental pathology (affective, anxious, hypochondriac, asthenic, psychotic) and reveals a number of characteristic features depending on the structure of the mental disorder. Psychopharmacotherapy for insomnia in mental disorders is an important aspect of patient supervision. Doxylamine (donormil) is one of the promising drugs for the correction of insomnia, both in combination with other psychotropic drugs and in monotherapy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
